Develop, manufacture, and sell genomic analysis oncology diagnostics
Food and Drug Administration regulatory policy generally and policy for approval of new oncology diagnostic technologies
Drug pricing reforms generally Medicare program policy for regulatory approval and reimbursement for new oncology diagnostic technologies
Reimbursement for new oncology diagnostic technologies generally
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
ARENTFOX SCHIFF LLP
1717 K Street, NW, Washington, DC, 20006, US
DAN RENBERG DAN RENBERG